From USAtoday.com….
Bobby Fentress learned about messenger RNA months before the rest of the world.
About a year before Fentress got his double shots of COVID-19 vaccine made with mRNA, the painting contractor was infused with a personalized version to fight his cancer.
Fentress, 68, was an early participant in a clinical trial intended to see whether a vaccine made with the same technology used to prevent COVID-19 could boost the immune system enough to search out and destroy lingering cancer cells.
Companies like Moderna and Pfizer’s partner BioNTech, whose names are familiar from COVID-19 vaccines, are using mRNA to spur cancer patients’ bodies to make vaccines that will – hopefully – prevent recurrences and treatments designed to fight off advanced tumors.
